comparemela.com

Latest Breaking News On - Voyager therapeutic - Page 1 : comparemela.com

Voyager Therapeutics (NASDAQ:VYGR) three-year earnings growth trails the splendid shareholder returns

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put.

Puma Biotechnology s Q1 Earnings and Revenues Beat - Ligand Pharmaceuticals (NASDAQ:LGND), ANI Pharmaceuticals (NASDAQ:ANIP)

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

While institutions own 30% of Voyager Therapeutics, Inc (NASDAQ:VYGR), individual investors are its largest shareholders with 42% ownership

Key Insights Significant control over Voyager Therapeutics by individual investors implies that the general public has.

Voyager Therapeutics Novartis deal has analysts bullish on stock s long-term outlook

Voyager Therapeutics Novartis deal has analysts bullish on stock s long-term outlook
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Chardan Capital Reaffirms Neutral Rating for Voyager Therapeutics (NASDAQ:VYGR)

Chardan Capital Reaffirms Neutral Rating for Voyager Therapeutics (NASDAQ:VYGR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.